Caruso J, Chen-Tanyolac C, Tlsty T
Breast Cancer Res. 2024; 26(1):184.
PMID: 39696672
PMC: 11657373.
DOI: 10.1186/s13058-024-01920-8.
Caruso J, Tlsty T
Res Sq. 2024; .
PMID: 39399685
PMC: 11469408.
DOI: 10.21203/rs.3.rs-4980285/v1.
Fakhri S, Moradi S, Abbaszadeh F, Faraji F, Amirian R, Sinha D
Cancer Metastasis Rev. 2024; 43(1):261-292.
PMID: 38169011
DOI: 10.1007/s10555-023-10161-8.
Vydra N, Toma-Jonik A, Janus P, Mrowiec K, Stokowy T, Glowala-Kosinska M
Cancers (Basel). 2023; 15(20).
PMID: 37894333
PMC: 10605143.
DOI: 10.3390/cancers15204965.
Rafnsdottir O, Kiuru A, Teback M, Friberg N, Revstedt P, Zhu J
Toxicol Rep. 2023; 10:509-520.
PMID: 37396848
PMC: 10313884.
DOI: 10.1016/j.toxrep.2023.04.001.
Sustained delivery of PARP inhibitor Talazoparib for the treatment of -deficient ovarian cancer.
Yang S, Green A, Brown N, Robinson A, Senat M, Testino B
Front Oncol. 2023; 13:1175617.
PMID: 37228496
PMC: 10203577.
DOI: 10.3389/fonc.2023.1175617.
Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide.
Bhattacharya U, Kamran M, Manai M, Cristofanilli M, Ince T
Cancers (Basel). 2023; 15(2).
PMID: 36672285
PMC: 9856736.
DOI: 10.3390/cancers15020332.
Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer.
Alshehri S, Pavlovic T, Farsinejad S, Behboodi P, Quan L, Centeno D
Adv Biol (Weinh). 2022; 6(12):e2200197.
PMID: 36084257
PMC: 9772079.
DOI: 10.1002/adbi.202200197.
ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin.
Kamran M, Bhattacharya U, Omar M, Marchionni L, Ince T
NPJ Breast Cancer. 2022; 8(1):99.
PMID: 36038558
PMC: 9424319.
DOI: 10.1038/s41523-022-00474-2.
Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insights.
Shendy N, Zimmerman M, Abraham B, Durbin A
Cell Rep Med. 2022; 3(5):100632.
PMID: 35584622
PMC: 9133465.
DOI: 10.1016/j.xcrm.2022.100632.
TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence.
Fang L, Li D, Yin J, Pan H, Ye H, Bowman J
Cancer Gene Ther. 2022; 29(10):1463-1476.
PMID: 35393570
PMC: 9537368.
DOI: 10.1038/s41417-022-00454-5.
Myoepithelial progenitors as founder cells of hyperplastic human breast lesions upon PIK3CA transformation.
Goldhammer N, Kim J, Villadsen R, Ronnov-Jessen L, Petersen O
Commun Biol. 2022; 5(1):219.
PMID: 35273332
PMC: 8913783.
DOI: 10.1038/s42003-022-03161-x.
Bidirectional Regulatory Cross-Talk between Cell Context and Genomic Aberrations Shapes Breast Tumorigenesis.
Kumar B, Bhat-Nakshatri P, Maguire C, Jacobsen M, Temm C, Sandusky G
Mol Cancer Res. 2021; 19(11):1802-1817.
PMID: 34285086
PMC: 8568628.
DOI: 10.1158/1541-7786.MCR-21-0163.
Evaluating the Epithelial-Mesenchymal Program in Human Breast Epithelial Cells Cultured in Soft Agar Using a Novel Macromolecule Extraction Protocol.
Lau H, Tang J, Casey P, Wang M
Cancers (Basel). 2021; 13(4).
PMID: 33671920
PMC: 7919038.
DOI: 10.3390/cancers13040807.
Cell of origin in biliary tract cancers and clinical implications.
Moeini A, Haber P, Sia D
JHEP Rep. 2021; 3(2):100226.
PMID: 33665585
PMC: 7902553.
DOI: 10.1016/j.jhepr.2021.100226.
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.
Sistigu A, Musella M, Galassi C, Vitale I, De Maria R
Front Immunol. 2020; 11:2166.
PMID: 33193295
PMC: 7609361.
DOI: 10.3389/fimmu.2020.02166.
Meta-analysis of gene expression profiling reveals novel basal gene signatures in MCF-10A cells transformed with cadmium.
Blommel K, Knudsen C, Wegner K, Shrestha S, Singhal S, Mehus A
Oncotarget. 2020; 11(39):3601-3617.
PMID: 33062196
PMC: 7533076.
DOI: 10.18632/oncotarget.27734.
HMGA1 Regulates the Stem Cell-Like Properties of Circulating Tumor Cells from GIST Patients via Wnt/β-Catenin Pathway.
Chen M, Xu K, Li B, Wang N, Zhang Q, Chen L
Onco Targets Ther. 2020; 13:4943-4956.
PMID: 32606726
PMC: 7296980.
DOI: 10.2147/OTT.S249063.
HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
Caslini C, Hong S, Ban Y, Chen X, Ince T
Oncogene. 2019; 38(39):6599-6614.
PMID: 31375747
DOI: 10.1038/s41388-019-0897-0.
Immortalization of Different Breast Epithelial Cell Types Results in Distinct Mitochondrial Mutagenesis.
Kwon S, Kim S, Nebeck H, Ahn E
Int J Mol Sci. 2019; 20(11).
PMID: 31181796
PMC: 6600575.
DOI: 10.3390/ijms20112813.